Nifty 50
- Eternal₹317.4012.95 (4.25%)
- Shriram Finance₹865-35.90 (-3.98%)
- Apollo Hospitals₹7,730125.50 (1.65%)
- Adani Enterprises₹2,477-73.00 (-2.86%)
- ONGC₹227.502.50 (1.11%)
- JSW Steel₹1,185.50-34.50 (-2.83%)
- Asian Paints₹2,30722.20 (0.97%)
- Jio Financial ₹205.03-5.77 (-2.74%)
- TCS₹2,53023.10 (0.92%)
- Tata Steel₹167.67-4.66 (-2.70%)
- UltraTech Cement₹11,05092.00 (0.84%)
- Adani Ports₹1,702.70-47.30 (-2.70%)
- Maruti Suzuki₹11,23060.00 (0.54%)
- Tech Mahindra₹1,790-39.10 (-2.14%)
- Cipla₹1,3387.10 (0.53%)
- Tata Motors PV₹264.60-5.40 (-2.00%)
- Reliance Industries₹1,1905.50 (0.46%)
- Hindalco Industries₹869.85-15.75 (-1.78%)
- Axis Bank₹1,217.505.50 (0.45%)
- Trent₹2,727.50-48.30 (-1.74%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Aurobindo Pharma Arm Launches Generic Version of Advair Diskus in US
Authored By PTI | Last Modified: Aug 31, 2026 04:37 PM IST
Open Free Demat Account
Open Free Demat Account
New Delhi: Aurobindo Pharma on Monday said its subsidiary Lannett Company LLC has launched a generic version of Advair Diskus, a product of GSK plc, in 100/50 mcg and 250/50 mcg strengths, in the US market.
Advair Diskus in combination therapy is indicated for the treatment of asthma and chronic obstructive pulmonary disease.
“This launch marks the first product from our inhalation pipeline to be commercialised in the US, reflecting our continued focus on expanding our portfolio of complex and differentiated inhalation products,” Aurobindo Pharma said in a regulatory filing on Monday.
Aurobindo Pharma Ltd is an integrated global pharmaceutical company headquartered in Hyderabad.
(Disclaimer: Except for the headline, this article has not been edited by HDFC Sky editorial team and is auto-generated from PTI feed.)
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
HDFC SKY, one of India’s most trusted trading platforms, has been recognized with the Next-Gen Digi Content Awards 2025–26.
Disclaimer
At HDFC SKY*, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations.
HDFC SKY from HDFC Securities, one of most trusted trading platforms in India, has been recognized with the *Next-Gen Digi Content Awards 2025-26.
Join Us
Add as preferred source on Google
More AUROPHARMA News
Open Free Demat Account
Open Free Demat Account
₹1,571.70
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy